Orient Pharma Co., Ltd.

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

N/A

Website

www.oppharma.com

Country

Taiwan

Exchange

Taipei Exchange

Founded 2008

Orient Pharma develops new drugs in Taiwan and globally. It offers cardiovascular drugs, such as Pitator and Tonvasca for lipid suppression, as well as Zulitor, a lipid lowering drug; psychotropic drugs Including Trokendi XR extended, Methydur, and powder and solvent for prolonged-release suspension for injection. Founded in 2008, the company is based in Taipei, Taiwan.

Key Stats

52-Week Range

NT$22.30NT$37.40

Beta0.09

Trailing P/E26.94

Forward P/EN/A

Trailing EPS0.90

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.